|
WO1997035584A1
(en)
*
|
1996-03-25 |
1997-10-02 |
Eli Lilly And Company |
Method for treating pain
|
|
ZA977967B
(en)
*
|
1996-09-23 |
1999-03-04 |
Lilly Co Eli |
Combination therapy for treatment of psychoses
|
|
ES2151828B1
(es)
|
1998-07-10 |
2001-08-16 |
Esteve Labor Dr |
Empleo de derivados de tetrahidropiridinas (ohidroxi-piperidinas)-b utilazoles en la elaboracion de un medicamento para el tratamiento del dolor.
|
|
DE69905938T2
(de)
*
|
1998-11-13 |
2003-11-13 |
Eli Lilly And Co., Indianapolis |
Kombination von duloxetin mit nichtsteroid-entzündungshemmern für die behandlung von schmerz
|
|
US6280763B1
(en)
|
1999-05-10 |
2001-08-28 |
Pierce Management, Llc |
Apparatus and method for transdermal delivery of bupropion
|
|
DE19924929C2
(de)
*
|
1999-05-31 |
2001-05-31 |
Elegene Gmbh |
Neues Verfahren zur Untersuchung der Eignung eines Materials als Pharmakon
|
|
ES2246488T3
(es)
|
1999-07-01 |
2006-02-16 |
PHARMACIA & UPJOHN COMPANY LLC |
Reboxetina para tratar la migraña.
|
|
US20060083691A1
(en)
*
|
2000-05-10 |
2006-04-20 |
Wermeling Daniel P |
Intranasal opioid compositions, delivery devices and methods of using same
|
|
US20040115133A1
(en)
*
|
2000-05-10 |
2004-06-17 |
Wermeling Daniel P. |
Intranasal opioid compositions
|
|
US6630462B2
(en)
|
2000-11-17 |
2003-10-07 |
Adolor Corporation |
Delta agonist analgesics
|
|
DE10112798A1
(de)
*
|
2001-03-16 |
2002-10-02 |
Elegene Gmbh |
Vorrichtung und Verfahren zur automatischen Erzeugung einer Wärmevermeidungsreaktion von Nematoden oder ähnlichen Lebewesen
|
|
US20070122353A1
(en)
|
2001-05-24 |
2007-05-31 |
Hale Ron L |
Drug condensation aerosols and kits
|
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
|
SE0102855D0
(sv)
*
|
2001-08-27 |
2001-08-27 |
Astrazeneca Ab |
Method of treatment
|
|
EP1434576A4
(en)
|
2001-09-13 |
2006-03-29 |
Kenneth E Miller |
METHOD FOR RELIEVING PAIN
|
|
US6635675B2
(en)
*
|
2001-11-05 |
2003-10-21 |
Cypress Bioscience, Inc. |
Method of treating chronic fatigue syndrome
|
|
US6602911B2
(en)
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
|
MXPA04007752A
(es)
*
|
2002-02-08 |
2005-06-17 |
Abbott Lab |
Terapia de combinacion para tratamiento de esquizofrenia.
|
|
EP1482921A1
(en)
*
|
2002-02-12 |
2004-12-08 |
Cypress Bioscience, Inc. |
Methods of treating attention deficit/hyperactivity disorder (adhd)
|
|
MXPA04009385A
(es)
*
|
2002-03-26 |
2005-01-25 |
Teva Pharma |
Microparticulas de drogas.
|
|
CN1662231A
(zh)
*
|
2002-04-24 |
2005-08-31 |
柏树生物科学公司 |
包括应激相关障碍在内的功能性躯体障碍的预防与治疗
|
|
US20040101481A1
(en)
*
|
2002-11-26 |
2004-05-27 |
Alexza Molecular Delivery Corporation |
Acute treatment of headache with phenothiazine antipsychotics
|
|
AU2003227521A1
(en)
*
|
2002-05-30 |
2003-12-19 |
Neurosearch A/S |
Combination of atypical antipsychotic and serotonin reuptake inhibitor for the treatment of chronic pain
|
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
|
AU2003284005B2
(en)
*
|
2002-10-03 |
2009-12-17 |
Forest Laboratories Holdings Limited |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
|
CA2507159A1
(en)
|
2002-11-26 |
2004-06-10 |
Alexza Molecular Delivery Corporation |
Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain
|
|
AR042806A1
(es)
|
2002-12-27 |
2005-07-06 |
Otsuka Pharma Co Ltd |
Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
|
|
NZ556779A
(en)
|
2002-12-27 |
2008-12-24 |
Otsuka Pharma Co Ltd |
Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
|
|
US20040234699A1
(en)
|
2003-05-21 |
2004-11-25 |
Alexza Molecular Delivery Corporation |
Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
|
|
MXPA05012538A
(es)
|
2003-05-23 |
2006-02-22 |
Otsuka Pharma Co Ltd |
Derivados de carbostirilo y estabilizantes del estado de animo para trastornos del mismo.
|
|
WO2004105690A2
(en)
*
|
2003-05-23 |
2004-12-09 |
Cypress Bioscience, Inc. |
Treatment of chronic pain associated with drug or radiation therapy
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
CA2580730C
(en)
*
|
2003-09-25 |
2015-01-13 |
Cenomed, Inc. |
Tetrahydroindolone derivatives for treatment of neurological conditions
|
|
US20050107439A1
(en)
*
|
2003-11-10 |
2005-05-19 |
Helton David R. |
Composition and method for treating emesis
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
MY147767A
(en)
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
|
EP2246086A3
(en)
|
2004-08-12 |
2012-11-21 |
Alexza Pharmaceuticals, Inc. |
Aerosol drug delivery device incorporating percussively activated heating unit
|
|
BRPI0610864A2
(pt)
|
2005-05-20 |
2010-08-03 |
Janssen Pharmaceutica Nv |
processo para preparação de derivados de sulfamida
|
|
UA97349C2
(uk)
*
|
2005-09-08 |
2012-02-10 |
Х. Луннбэк А/С |
Стійкі тверді склади сертиндолу
|
|
US7994220B2
(en)
*
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
|
EP1795609A1
(en)
|
2005-12-06 |
2007-06-13 |
Sanofi-Aventis Deutschland GmbH |
Method for the diagnosis and treatment of cardiovascular diseases
|
|
WO2007067714A2
(en)
*
|
2005-12-08 |
2007-06-14 |
The Mclean Hospital Corporation |
Treatment of sequelae of psychiatric disorders
|
|
AR058389A1
(es)
|
2005-12-19 |
2008-01-30 |
Janssen Pharmaceutica Nv |
Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
|
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
|
US8497298B2
(en)
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
|
US8691867B2
(en)
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
|
JP2009537635A
(ja)
|
2006-05-19 |
2009-10-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
癲癇の処置のための共同−療法
|
|
EP2121088B1
(en)
|
2007-03-09 |
2016-07-13 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
|
WO2008128166A1
(en)
*
|
2007-04-13 |
2008-10-23 |
Concert Pharmaceuticals Inc. |
Deuterated derivatives of 4-(6-fluoro-1, 2-benzisoxazol-3-yl) piperidine compounds
|
|
WO2009062134A1
(en)
*
|
2007-11-09 |
2009-05-14 |
Cenomed Biosciences, Llc |
Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
|
|
US20090264443A1
(en)
*
|
2008-04-18 |
2009-10-22 |
David Helton |
Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
|
|
PE20110060A1
(es)
|
2008-06-23 |
2011-01-31 |
Janssen Pharmaceutica Nv |
Forma cristalina de (2s)-(-)-n-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
|
|
US8815939B2
(en)
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
|
US8697735B2
(en)
|
2008-07-25 |
2014-04-15 |
Bionevia Pharmaceuticals, Inc. |
Solid forms of epalrestat
|
|
CN102216281B
(zh)
|
2008-09-06 |
2014-11-05 |
碧奥尼维亚制药股份有限公司 |
依帕司他的新胆碱共结晶
|
|
AU2012384456B2
(en)
*
|
2012-07-02 |
2018-02-15 |
Pnb Vesper Life Science Pvt Limited |
Novel cholecystokinin receptor ligands
|
|
WO2014078568A1
(en)
|
2012-11-14 |
2014-05-22 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
|
AU2014369916A1
(en)
|
2013-12-24 |
2016-06-16 |
Durect Corporation |
Uses of oxygenated cholesterol sulfates (OCS)
|
|
EP3468540A4
(en)
*
|
2016-06-13 |
2020-03-18 |
Board Of Regents Of the University Of Texas System |
PHARMACEUTICAL COMPOSITIONS AND METHOD FOR TREATING PAIN
|
|
US12459965B2
(en)
|
2017-10-09 |
2025-11-04 |
Compass Pathfinder Limited |
Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
|
|
GB2571696B
(en)
|
2017-10-09 |
2020-05-27 |
Compass Pathways Ltd |
Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
|
|
US12214118B2
(en)
|
2018-02-02 |
2025-02-04 |
Alexza Pharmaceuticals, Inc. |
Electrical condensation aerosol device
|
|
JP2022529781A
(ja)
|
2019-04-17 |
2022-06-24 |
コンパス パスファインダー リミテッド |
サイロシビンによるうつ病及び他の様々な障害の治療
|
|
US12389955B2
(en)
*
|
2021-10-22 |
2025-08-19 |
Nike, Inc. |
Garment adjusting system
|
|
US11977085B1
(en)
|
2023-09-05 |
2024-05-07 |
Elan Ehrlich |
Date rape drug detection device and method of using same
|